Oncotelic Therapeutics (OTLC) Stock Chart & Stock Price History $0.03 +0.01 (+22.05%) (As of 11/22/2024 03:29 PM ET) Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Oncotelic Therapeutics Stock Price Performance 5 Day Performance+3.33%1 Month Performance-11.43%3 Month Performance+49.76%6 Month Performance-13.89%Year-To-Date Performance-18.95%1 Year Performance-9.94% Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. OTLC Stock Chart for Saturday, November, 23, 2024 OTLC Chart by TradingView Oncotelic Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$0.03$0.03+22.05%$0.03$0.03187,824 shs$12.59 million11/21/2024$0.02$0.03+20.95%$0.03$0.0227,799 shs$10.32 million11/20/2024$0.03$0.02-32.04%$0.03$0.02885,919 shs$8.53 million11/19/2024$0.03$0.03+3.00%$0.03$0.0325,330 shs$12.55 million11/18/2024$0.03$0.03+0.50%$0.03$0.03500 shs$12.19 million11/15/2024$0.03$0.03+7.55%$0.03$0.03154,460 shs$12.15 million Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$0.03$0.03+5.70%$0.03$0.0337,241 shs$11.29 million11/13/2024$0.03$0.03-12.04%$0.03$0.03187,311 shs$10.69 million11/12/2024$0.03$0.03-3.55%$0.03$0.0326,600 shs$12.15 million11/11/2024$0.03$0.03+0.58%$0.03$0.0376,513 shs$12.59 million11/08/2024$0.03$0.03+6.21%$0.03$0.03249,950 shs$11.17 million11/07/2024$0.03$0.03+5.45%$0.03$0.021.43 million shs$11.78 million11/06/2024$0.03$0.03-5.50%$0.03$0.03195,590 shs$11.17 million11/05/2024$0.03$0.03-7.32%$0.03$0.03142,548 shs$11.82 million11/04/2024$0.03$0.03-4.85%$0.03$0.03148,450 shs$12.76 million11/01/2024$0.03$0.03+2.33%$0.03$0.0323,808 shs$13.41 million10/31/2024$0.03$0.03-5.15%$0.03$0.0371,313 shs$13.10 million10/30/2024$0.04$0.03-6.85%$0.04$0.03271,765 shs$13.81 million10/29/2024$0.03$0.04+18.51%$0.04$0.03365,510 shs$14.83 million10/28/2024$0.04$0.03-12.00%$0.03$0.03325,998 shs$12.51 million10/25/2024$0.03$0.04+1.74%$0.04$0.04176,317 shs$14.22 million10/24/2024$0.04$0.03-1.71%$0.04$0.0332,222 shs$13.98 million10/23/2024$0.04$0.04-4.11%$0.04$0.0361,000 shs$14.22 million10/22/2024$0.04$0.04+1.39%$0.04$0.04174,638 shs$14.83 million Related Companies RLYB Stock Price Chart ETST Stock Price Chart BRNS Stock Price Chart ANEB Stock Price Chart FSDDF Stock Price Chart CVM Stock Price Chart LUMO Stock Price Chart OSTX Stock Price Chart CERO Stock Price Chart OKYO Stock Price Chart Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OTLC) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
